segunda-feira, 22 de outubro de 2012

Genzyme inks $22.5M deal with Alnylam on rare - SMTP

http://tinyurl.com/8q5y256 - Heart Disease Risk Factors Also Tied to Death From Prostate Cancer

The study authors noted that by following health recommendations on diet and exercise to prevent heart disease and diabetes, men can also lower their risk of death from this form of cancer. Researchers from Umea University in Sweden, led by Dr. Par ...Blood pressure linked to death riskKuwait News AgencyProstate Cancer Death Risk Raised By Metabolic FactorsMedical News Todayall 13 news articles »

'Blue Bloods': Jennifer Esposito claims celiac disease got her axed

'Blue Bloods': Jennifer Esposito claims celiac disease got her axedOne of the lead actors on the CBS drama Blue Bloods, Jennifer Esposito, is taking to Twitter to air her grievances claiming she was written out of the show due to a medical condition. The feud between Esposito, who plays Detective Jackie Curatola, and ...Jennifer Esposito angry over 'Blue Bloods' 'leave of absence' due to Celiac ...Zap2it.com (blog)Jennifer Esposito: Blue Bloods Bosses Write Her Out of Show Because of Celiac ...Showbiz SpyJennifer Esposito: Celiac Disease Made Her Leave 'Blue Bloods', CBS Wants to ...Franchise HeraldChristian Post -Monsters and Critics.com -San Francisco Luxury Newsall 52 news articles »

Genzyme inks $22.5M deal with Alnylam on rare

-Alnylam Pharmaceuticals Inc. and Genzyme said today they have formed an exclusive alliance to develop and commercialize RNA interference therapeutics targeting transthyretin for treating transthyretin-mediated amyloidosis in Asia. Under terms of the ...Genzyme pays $22.5M upfront to bag Asian rights to Alnylam's hot ATTR programFierceBiotechAlnylam Gets $22.5M From Genzyme for Asia Rights to Amyloidosis DrugXconomyall 22 news articles »

Sem comentários:

Enviar um comentário